Details for New Drug Application (NDA): 206432
✉ Email this page to a colleague
The generic ingredient in NATEGLINIDE is nateglinide. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nateglinide profile page.
Summary for 206432
Tradename: | NATEGLINIDE |
Applicant: | Cadila Pharms Ltd |
Ingredient: | nateglinide |
Patents: | 0 |
Pharmacology for NDA: 206432
Mechanism of Action | Potassium Channel Antagonists |
Suppliers and Packaging for NDA: 206432
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NATEGLINIDE | nateglinide | TABLET;ORAL | 206432 | ANDA | Cadila Pharmaceuticals Limited | 71209-030 | 71209-030-04 | 90 TABLET, COATED in 1 BOTTLE (71209-030-04) |
NATEGLINIDE | nateglinide | TABLET;ORAL | 206432 | ANDA | Cadila Pharmaceuticals Limited | 71209-030 | 71209-030-05 | 100 TABLET, COATED in 1 BOTTLE (71209-030-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
Approval Date: | Apr 19, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 120MG | ||||
Approval Date: | Apr 19, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription